205 related articles for article (PubMed ID: 30663175)
1. Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participants.
Masuy I; Tack J; Verbeke K; Carbone F
Neurogastroenterol Motil; 2019 Apr; 31(4):e13540. PubMed ID: 30663175
[TBL] [Abstract][Full Text] [Related]
2. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
4. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
[TBL] [Abstract][Full Text] [Related]
5. Effect of acotiamide on gastric emptying in healthy adult humans.
Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
[TBL] [Abstract][Full Text] [Related]
6. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
7. The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population.
Masuy I; Carbone F; Holvoet L; Vandenberghe A; Vanuytsel T; Tack J
Neurogastroenterol Motil; 2020 Feb; 32(2):e13739. PubMed ID: 31608532
[TBL] [Abstract][Full Text] [Related]
8. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study.
Muta K; Ihara E; Fukaura K; Tsuchida O; Ochiai T; Nakamura K
Digestion; 2016; 94(1):9-16. PubMed ID: 27326454
[TBL] [Abstract][Full Text] [Related]
9. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
Yamawaki H; Futagami S; Kawagoe T; Maruki Y; Hashimoto S; Nagoya H; Sato H; Kodaka Y; Gudis K; Akamizu T; Sakamoto C; Iwakiri K
Neurogastroenterol Motil; 2016 Jul; 28(7):1037-47. PubMed ID: 26920949
[TBL] [Abstract][Full Text] [Related]
10. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.
Ishimura N; Mori M; Mikami H; Shimura S; Uno G; Aimi M; Oshima N; Ishihara S; Kinoshita Y
BMC Gastroenterol; 2015 Sep; 15():117. PubMed ID: 26362795
[TBL] [Abstract][Full Text] [Related]
11. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.
Tack J; Janssen P
Expert Opin Investig Drugs; 2011 May; 20(5):701-12. PubMed ID: 21417958
[TBL] [Abstract][Full Text] [Related]
12. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.
Verhagen MA; Samsom M; Maes B; Geypens BJ; Ghoos YF; Smout AJ
Aliment Pharmacol Ther; 1997 Dec; 11(6):1077-86. PubMed ID: 9663833
[TBL] [Abstract][Full Text] [Related]
14. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
[TBL] [Abstract][Full Text] [Related]
15. Novel Prokinetic Acotiamide Reduces Transient Lower Esophageal Sphincter Relaxation in Healthy Subjects.
Yamashita H; Kanamori A; Fukuchi T; Tsujimae M; Koizumi A; Iwatsubo T; Koyama S; Eguchi T; Ubukata S; Fujita M; Okada A
Digestion; 2015; 92(2):90-8. PubMed ID: 26279051
[TBL] [Abstract][Full Text] [Related]
16. Physiological characterization of gastric emptying using high-resolution antropyloroduodenal manometry.
Soliman H; Wuestenberghs F; Desprez C; Leroi AM; Melchior C; Gourcerol G
Am J Physiol Gastrointest Liver Physiol; 2024 Jan; 326(1):G16-G24. PubMed ID: 37874655
[TBL] [Abstract][Full Text] [Related]
17. Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion.
Rotondo A; Janssen P; Mulè F; Tack J
Int J Obes (Lond); 2013 May; 37(5):693-8. PubMed ID: 22846777
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitric oxide on antral motility and gastric emptying in humans.
Konturek JW; Thor P; Domschke W
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):97-102. PubMed ID: 7712314
[TBL] [Abstract][Full Text] [Related]
19. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
[TBL] [Abstract][Full Text] [Related]
20. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
Kwiatek MA; Fox MR; Steingoetter A; Menne D; Pal A; Fruehauf H; Kaufman E; Forras-Kaufman Z; Brasseur JG; Goetze O; Hebbard GS; Boesiger P; Thumshirn M; Fried M; Schwizer W
Neurogastroenterol Motil; 2009 Sep; 21(9):928-e71. PubMed ID: 19413683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
